T. Edwards

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

R. Weinshilboum, S. Oparil, J. Cleeman, 1997, Archives of internal medicine.

Cantuzumab mertansine, a maytansinoid immunoconjugate directed to the CanAg antigen: a phase I, pharmacokinetic, and biologic correlative study.

A. Tolcher, C. Takimoto, L. Smith, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cantuzumab M ertansine, a M aytansinoid I mmunoconjugate Directed t o t he C anAg A ntigen: A P hase I , P harmacokinetic, and B iologic C orrelative S tudy

A. Tolcher, C. Takimoto, L. Smith, 2003 .

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

A. Tolcher, C. Geyer, L. Denis, 2003, British Journal of Cancer.

The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (NIH Publication No. 98-4080)

R. Weinshilboum, S. Oparil, J. Cleeman, 1997 .